PT86539A - Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer - Google Patents
Pharmaceutical composition for the prophylaxis and therapy of gastric ulcerInfo
- Publication number
- PT86539A PT86539A PT86539A PT8653988A PT86539A PT 86539 A PT86539 A PT 86539A PT 86539 A PT86539 A PT 86539A PT 8653988 A PT8653988 A PT 8653988A PT 86539 A PT86539 A PT 86539A
- Authority
- PT
- Portugal
- Prior art keywords
- prophylaxis
- therapy
- pharmaceutical composition
- gastric ulcer
- sulglycotide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8719048A IT1215332B (it) | 1987-01-12 | 1987-01-12 | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
Publications (2)
Publication Number | Publication Date |
---|---|
PT86539A true PT86539A (en) | 1988-02-01 |
PT86539B PT86539B (pt) | 1991-12-31 |
Family
ID=11154112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT86539A PT86539B (pt) | 1987-01-12 | 1988-01-12 | Processo de preparacao de composicoes farmaceuticas contendo sulglicotido e um polimero hidrofilico |
Country Status (9)
Country | Link |
---|---|
US (2) | US4937079A (pt) |
EP (1) | EP0274745B1 (pt) |
JP (1) | JP2587441B2 (pt) |
AT (1) | ATE69167T1 (pt) |
DE (1) | DE3774415D1 (pt) |
ES (1) | ES2040239T3 (pt) |
GR (1) | GR3003555T3 (pt) |
IT (1) | IT1215332B (pt) |
PT (1) | PT86539B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1215332B (it) * | 1987-01-12 | 1990-02-08 | Crinos Industria Farmaco | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
IT1230157B (it) * | 1989-06-16 | 1991-10-14 | Lisapharma Spa | Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica |
US5102916A (en) * | 1990-07-03 | 1992-04-07 | Jacques Antoun | Method of relieving gastric ulcers with carob extract |
IT1246188B (it) * | 1990-07-27 | 1994-11-16 | Resa Farma | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
WO1993019765A1 (en) * | 1992-04-06 | 1993-10-14 | Jacques Antoun | Oak and carob bark composition for relieving gastric ulcers |
ITMI20040989A1 (it) * | 2004-05-18 | 2004-08-18 | Gentium Spa | Uso del sulglicotide per iul trattamento delle mucositi |
KR100883999B1 (ko) * | 2004-05-18 | 2009-02-17 | 젠티엄 에스피에이 | 점막염 치료를 위한 설글리코타이드의 용도 |
KR101088781B1 (ko) | 2010-04-13 | 2011-12-01 | 삼일제약주식회사 | 설글리코타이드-함유 경구용 액상 제제 |
KR101088779B1 (ko) | 2010-04-13 | 2011-12-01 | 삼일제약주식회사 | 설글리코타이드-함유 경구용 액상 제제 |
JPWO2015076294A1 (ja) * | 2013-11-22 | 2017-03-16 | キユーピー株式会社 | 薬剤の副作用である胃潰瘍の発症抑制方法、および胃潰瘍発症が抑制された経口薬剤組成物ならびにその製造方法 |
KR101819709B1 (ko) * | 2017-01-13 | 2018-01-17 | (주)아이엠디팜 | 설글리코타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 약학 조성물 |
KR102270073B1 (ko) * | 2019-10-24 | 2021-06-28 | 삼일제약주식회사 | 설글리코타이드를 유효성분으로 포함하는 염증성 장질환의 예방 또는 치료용 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3522229A (en) * | 1967-03-29 | 1970-07-28 | Teikoku Hormone Mfg Co Ltd | Glycoprotein from saliva or salivary glands having gastric acid secretion inhibitory as well as anti-ulcerative activity and method of collecting the same |
GB1269987A (en) * | 1968-04-18 | 1972-04-12 | Garland Richard Brown | Antacid composition |
GB1249907A (en) * | 1969-05-27 | 1971-10-13 | Prephar Prospection De Rech S | Process for the sulphonation of a glycopeptide |
IT1061352B (it) * | 1973-03-27 | 1983-02-28 | Crinos Industria Farmaco | Sali misti di esteri polisolforici di glicopeptidi naturali con metalli e con basi organiche e procedimento per la loro preparazione |
US3961045A (en) * | 1973-10-23 | 1976-06-01 | National Starch And Chemical Corporation | Method of treating ulcer |
US4151276A (en) * | 1975-05-12 | 1979-04-24 | Armour Pharmaceutical Company | Method of suppressing gastric acid secretion by the oral administration of calcitonin |
IT1215332B (it) * | 1987-01-12 | 1990-02-08 | Crinos Industria Farmaco | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
-
1987
- 1987-01-12 IT IT8719048A patent/IT1215332B/it active
- 1987-12-28 AT AT87119247T patent/ATE69167T1/de not_active IP Right Cessation
- 1987-12-28 US US07/138,400 patent/US4937079A/en not_active Expired - Fee Related
- 1987-12-28 EP EP87119247A patent/EP0274745B1/en not_active Expired - Lifetime
- 1987-12-28 DE DE8787119247T patent/DE3774415D1/de not_active Expired - Fee Related
- 1987-12-28 ES ES198787119247T patent/ES2040239T3/es not_active Expired - Lifetime
-
1988
- 1988-01-11 JP JP63002660A patent/JP2587441B2/ja not_active Expired - Lifetime
- 1988-01-12 PT PT86539A patent/PT86539B/pt not_active IP Right Cessation
-
1990
- 1990-03-30 US US07/501,698 patent/US5085867A/en not_active Expired - Fee Related
-
1992
- 1992-01-09 GR GR920400013T patent/GR3003555T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT86539B (pt) | 1991-12-31 |
ES2040239T3 (es) | 1993-10-16 |
US4937079A (en) | 1990-06-26 |
JP2587441B2 (ja) | 1997-03-05 |
JPS63253029A (ja) | 1988-10-20 |
US5085867A (en) | 1992-02-04 |
EP0274745B1 (en) | 1991-11-06 |
IT1215332B (it) | 1990-02-08 |
GR3003555T3 (pt) | 1993-03-16 |
EP0274745A1 (en) | 1988-07-20 |
ATE69167T1 (de) | 1991-11-15 |
DE3774415D1 (de) | 1991-12-12 |
IT8719048A0 (it) | 1987-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0353581A3 (en) | Pharmaceutical compositions comprising selected lactobacillus strains | |
HK14294A (en) | Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid | |
AU1467888A (en) | Agent for the prophylaxis and therapy of retroviral infections | |
HK184896A (en) | Pharmaceutical composition comprising loratadine ibuprofen and pseudoephedrine | |
AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
PT86539A (en) | Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer | |
EP0276543A3 (en) | Use of buspirone for the improvement of short term memory | |
IL103213A (en) | Medicaments for treating gastrointestinal disorders containing ranitidine bismuth citrate together with certain helicobacter pylori-inhibiting antibiotics | |
EP0304802A3 (en) | Pharmaceutical composition and the use thereof | |
AU8188087A (en) | Variants of hirudin, their use and their preparation | |
AU2616788A (en) | Device for use in the treatment of lymphocytes | |
AU2351688A (en) | Vulcanizable fluororubber composition | |
NZ223293A (en) | Beta-alkyl melatonins and pharmaceutical compositions | |
PH24723A (en) | Device and composition for treatment of the gums | |
ATE19855T1 (de) | Pharmazeutische und diaetetische zusammensetzung. | |
EP0159602A3 (en) | Compositions and methods for the therapeutic treatment of trace element deficiencies in ruminant animals | |
AU613510B2 (en) | Use of zofenopril for the treatment of rheumatoid arthritis | |
NZ219403A (en) | 1,3,4,9-tetrahydropyrano(3,4-b indole-1-acetic acid derivatives and pharmaceutical compositions | |
IL79207A0 (en) | Pharmaceutical compositions containing terguide | |
EP0169684A3 (en) | Pharmaceutical compositions | |
GR3005838T3 (pt) | ||
ZA816799B (en) | Pharmaceutical compositions for the treatment of gastric hyperacidity,gastritis and gastro-duodenal ulcers | |
ZA865017B (en) | A pharmaceutical composition for the treatment and/or prophylaxis of hyperglycaemia | |
IT1244360B (it) | Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale | |
CS706887A1 (en) | Device for veneer jointing and sticking with the base |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19981231 |